PROCEPT BioRobotics logo

PROCEPT BioRobotics

PRCT | NASDAQ
Chart Builder DCF Calculator
$23.54
-$0.26 (-1.09%)
At close: Nov 16, 2026, 4:00 PM ET
$23.00
-$0.54 (-2.29%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.09%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
43.9
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #424/1021 (Top 42%)

Key Statistics

Market Data

Market Cap $1.35B
1D Range
23.22 24.29
52W Range
16.69 36.10

Valuation (TTM)

PE -11.65
PB 4.12
EV/EBITDA -11.75

Valuation (NTM)

Forward PE N/A
Forward PEG -0.92
Price Target $21.00
Loading financial charts...

Profile

PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System,...

Sector Healthcare
Employees 888
IPO Date Sep 15, 2021
Fiscal Year January - December

Latest News

PROCEPT BioRobotics Q3 Earnings Call Highlights

12 days ago · marketbeat.com

PROCEPT BioRobotics Q3 Earnings Call Highlights
PROCEPT BioRobotics Corporation (PRCT) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

PROCEPT BioRobotics Corporation (PRCT) Q3 2026 Earnings Call Transcript
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates

12 days ago · zacks.com

PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

20 days ago · zacks.com

PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth

25 days ago · seekingalpha.com

PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth
PROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors

28 days ago · gurufocus.com

PROCEPT BioRobotics Corp (PRCT) Shares Surge 4.0% -- What GF Score of 71 Tells Investors
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

1 month ago · globenewswire.com

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation

2 months ago · globenewswire.com

LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation
LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation

2 months ago · prnewswire.com

LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.46
Miss -17.49%
REV
$98.29M
Miss -2.22%
Next Earnings
Feb 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
11
Consensus
Hold
Price Target
$21.00
Downside
-10.79%
Buy (5)
Hold (5)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.